Biotech Values

[pcrutch]

When I spoke to them, they said they would like to partner out the worldwide rights.

- Extremely confident that it gets partnered.
- They said the SGEN deal might be a reasonable guide as to what to expect for their partnership ( like 60-70 mil upfront – high double digits royalty).
- Willing to give up a big upfront payment in order to not have to pay for development.

I think this is a smart move given the large number of trials they need to run, since you're talking combo trials, single-agent across different lines of therapy.